Brussels South Charleroi BioPark Dev
0479.250.670 · rovalta.com · 24/09/2026
ACTIVE
Brussels South Charleroi BioPark Dev
Financial year 2025 · Closed on 31/12/2025
Net result
-248,8 k €
+43,2 %over 1 yearGross margin
80,2 k €
+144,6 %over 1 yearEquity
327,5 k €
+0,4 %over 1 yearWorkforce
3,8 ETP
+8,6 %over 1 yearOverview
Identity
Source · BCE/KBOBrussels South Charleroi BioPark Dev is a Public limited company incorporated in 2003. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 3,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0479.250.670
- Incorporation
- 09/01/2003
- Legal form
- Public limited company
- Registered office
- Rue Clément Ader 10
6041 Charleroi · WallonieSee on map - Contributed capital
- 1 175 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,8 ETP
Activities (NACE)
72109Research and experimental development on natural sciences and engineering· main72190Other research and experimental development on natural sciences and engineering73100Advertising82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.+1
Joint committees (2)
- 200
- 218
Signals
Solid equityGood liquidityHealthy social debts
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 80,2 k € | +145% | -179,8 k € | -116% | -83 k € | -204% | 79,8 k € | -45.9% | 147,4 k € |
| EBITDA | -200 k € | +50.3% | -402,3 k € | -166% | -151,1 k € | -1003% | 16,7 k € | +198% | -17,1 k € |
| Operating result | -244,7 k € | +43.9% | -436,4 k € | -170% | -161,5 k € | -1670% | 10,3 k € | +3032% | -350,9 € |
| Net result | -248,8 k € | +43.2% | -437,8 k € | -169% | -162,8 k € | -2757% | 6,1 k € | +170% | -8,8 k € |
| Balance sheet | |||||||||
| Equity | 327,5 k € | +0.4% | 326,3 k € | -36.5% | 514 k € | -24.1% | 676,9 k € | +0.9% | 670,7 k € |
| Total assets | 668,8 k € | +34.0% | 499,1 k € | -29.2% | 704,5 k € | -7.9% | 764,9 k € | -1.3% | 774,6 k € |
| Cash | 105 k € | +46.7% | 71,6 k € | -80.3% | 363,4 k € | +72.6% | 210,5 k € | -54.6% | 463,4 k € |
| Debts | 238 k € | +110% | 113,2 k € | -29.1% | 159,7 k € | +183% | 56,3 k € | -14.5% | 65,9 k € |
| Other | |||||||||
| Workforce | 3,8 ETP | +8.6% | 3,5 ETP | +94.4% | 1,8 ETP | – | 2,0 ETP | ||
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/202515 active · 82 ended
Active mandates
Active
Active
Active
Active
Cédric SZPIRER
ActiveDenis LESOIL
ActiveBrigitte GOSSIAUX
ActiveDaniele CARATI
ActiveMichel COULON
ActiveNathalie CZERNIATYNSKI
ActiveCéline THILLOU
ActiveDominique DEMONTE
ActiveEnded mandates
Other companies at this address
Rue Clément Ader 10 6041 Charleroi| Company | CBE no. |
|---|---|
2 Bridge WL● Active | 1003.906.745 |
3D Fibroscreen● Active | 1022.772.354 |
AdipoPharma Belgique● Active | 1008.146.338 |
ATRYON BELGIUM● Active | 0751.698.530 |
ConvEyXo● Active | 0725.874.259 |
CONVEYXO GROUP● Active | 1016.957.797 |
ELKEDONIA BELGIUM● Active | 1021.635.177 |
ENDO TOOLS THERAPEUTICS● Active | 0807.570.233 |
Enodia Therapeutics Belgium● Active | 1039.324.811 |
EU BIOTECH CAMPUS● Active | 0776.668.706 |
Exo-Harvest● Active | 0803.425.264 |
Hemastatx● Active | 1019.406.058 |
Immunofusion● Active | 0804.563.629 |
ImmunXperts● Active | 0552.755.587 |
INCHINN THERAPEUTICS● Active | 0799.914.755 |
INSTAR BELGIQUE● Active | 1039.395.085 |
KOKUMA● Active | 0799.078.377 |
LYS MEDICAL● Active | 0688.626.061 |
MILEUTIS● Active | 1011.400.984 |
Nexelis Europe● Active | 0744.498.061 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/06/2026 | 17/07/2025 | 24/06/2024 | 20/06/2023 | 23/06/2022 | 31/08/2021 |
| General meeting | 15/06/2026 | 16/06/2025 | 17/06/2024 | 19/06/2023 | 20/06/2022 | 17/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 15/06/2026 | 17/06/2026 | French | |
| Abridged model | 31/12/2024 | 16/06/2025 | 17/07/2025 | French | |
| Abridged model | 31/12/2023 | 17/06/2024 | 24/06/2024 | French | |
| Abridged model | 31/12/2022 | 19/06/2023 | 20/06/2023 | French | |
| Abridged model | 31/12/2021 | 20/06/2022 | 23/06/2022 | French | |
| Abridged model | 31/12/2020 | 17/06/2021 | 31/08/2021 | French | |
| Abridged model | 31/12/2019 | 14/05/2020 | 16/06/2020 | French | |
| Abridged model | 31/12/2018 | 17/06/2019 | 19/07/2019 | French | |
| Abridged model | 31/12/2017 | 19/06/2018 | 21/06/2018 | French | |
| Abridged model | 31/12/2016 | 05/07/2017 | 12/07/2017 | French | |
| Abridged model | 31/12/2015 | 05/07/2016 | 12/07/2016 | French | |
| Abridged model | 31/12/2014 | 15/06/2015 | 17/06/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 29/07/2014 | French | |
| Abridged model | 31/12/2012 | 20/06/2013 | 31/07/2013 | French | |
| Abridged model | 31/12/2011 | 04/06/2012 | 20/06/2012 | French | |
| Abridged model | 31/12/2010 | 23/05/2011 | 26/09/2011 | French | |
| Abridged model | 31/12/2009 | 05/05/2010 | 31/08/2010 | French | |
| Abridged model | 31/12/2008 | 24/07/2009 | 31/07/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 21/08/2008 | French | |
| Abridged model | 31/12/2006 | 29/05/2007 | 08/04/2008 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202515 active · 82 ended
Active mandates
Active
Active
Active
Active
Cédric SZPIRER
ActiveDenis LESOIL
ActiveBrigitte GOSSIAUX
ActiveDaniele CARATI
ActiveMichel COULON
ActiveNathalie CZERNIATYNSKI
ActiveCéline THILLOU
ActiveDominique DEMONTE
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates25/07/2025DEMISSIONS, NOMINATIONS
- Mandates25/10/2024DEMISSIONS, NOMINATIONS
- Mandates25/10/2024DEMISSIONS, NOMINATIONS
- Mandates25/10/2024DEMISSIONS, NOMINATIONS
- Mandates04/10/2024DEMISSIONS, NOMINATIONS
- Capital / shares29/07/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Capital / shares04/03/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Registered office19/01/2024SIEGE SOCIAL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-248,8 k €↑
- 2024Annual accounts 2024-437,8 k €↓
- 2023Annual accounts 2023-162,8 k €↓
- 2022Annual accounts 20226,1 k €↑
- 2021Annual accounts 2021-8,8 k €↓
- 2020Annual accounts 202016,4 k €↓
- 2020Name changeBrussels South Charleroi BioPark Dev
- 2019Annual accounts 201948,5 k €↓
- 2018Annual accounts 201884,5 k €↑
- 2018Name changeCharleroi Brussel South Biopark Dev
- 2017Annual accounts 2017-168,5 k €↓
- 2016Annual accounts 201638 k €↑
- 2015Annual accounts 2015-1,5 k €↓
- 2014Annual accounts 20148,6 k €↑
- 2013Annual accounts 20133 k €↑
- 2012Annual accounts 2012-20,9 k €↓
- 2012Name changei - Tech Incubator
- 2011Annual accounts 20111,3 k €↓
- 2010Annual accounts 201013 k €↑
- 2009Annual accounts 2009-941 €↑
- 2008Annual accounts 2008-1,5 k €↓
- 2007Annual accounts 2007-1,1 k €↓
- 2006Annual accounts 2006-726 €
- 2006Name changeWALLONIA BIOTECH
- 09/01/2003IncorporationPublic limited company